T2 Biosystems, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
TTOO on OTC
Location
101 Hartwell Avenue, Lexington, MA

There are no Buy or Sell transactions made by insiders since 10/13/2024

T2 Biosystems, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
CR Group L.P. 10%+ Owner $741K May 9, 2024
Goldman Sachs & Co. Llc 10%+ Owner $662K Mar 24, 2020
Adrian M. Jones Director $662K Mar 24, 2020
Aparna Ahuja Chief Medical Officer $111K Feb 20, 2022
John McDonough Director $94.2K Jul 1, 2021
John J. Sperzel III Chairman, President & CEO, Director $77.2K Nov 4, 2024
Alec Barclay Chief Operations Officer $32.1K Apr 8, 2022
Michael Terrence Gibbs General Counsel $29.9K Nov 4, 2024
John Sprague Cfo $28.4K Nov 4, 2024
Brett A. Giffin Chief Commercial Officer $28.4K Nov 4, 2024
John W. Cumming Director $5.51K Nov 4, 2024
David B. Elsbree Director $4K Nov 4, 2024
Laura Lee Adams Director $3.94K Nov 4, 2024
Ninfa Saunders Director $3.94K Nov 4, 2024
Robin Toft Director $3.94K Nov 4, 2024
Seymour Liebman Director $3.94K Nov 4, 2024
Thierry Bernard Director $1.15K Sep 15, 2023

Recent Insider Transactions by Companies or Individuals for T2 Biosystems, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.